Business UpdateJul 7, 2026, 07:01 PM
Quantum Biopharma Retains FinnCom for Marketing Services for $170,500
AI Summary
Quantum Biopharma Ltd. announced it has retained FinnCom, Inc. for a six-month contract, starting June 24, 2026, to provide marketing and investor awareness services. The agreement includes an initial payment of USD 20,500 and six subsequent monthly payments of USD 25,000, totaling USD 170,500. FinnCom, an arm's-length firm, will focus on corporate branding, social media, and advertising initiatives.
Key Highlights
- Quantum Biopharma retained FinnCom, Inc. for marketing and investor awareness services.
- The contract is for six months, starting June 24, 2026, with an option for renewal.
- FinnCom will design and execute campaigns including corporate branding, social media, and advertising.
- The company will pay FinnCom an initial USD 20,500 at contract initiation.
- Six monthly payments of USD 25,000 will be made from July to December 2026.
- Total cash consideration to FinnCom for the initial contract period is USD 170,500.
- FinnCom does not own any shares, options, or warrants in Quantum Biopharma.
Price Impact
More from QNTM